Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Ohara Gains Rights to BTG's Glucarpidase in Japan - Genetic Engineering News |
![]() |
![]() |
Genetic Engineering News Glucarpidase is an experimental treatment for the rapid and sustained reduction of toxic methotrexate (MTX) levels due to impaired renal function. Under terms of the agreement BTG will also supply glucarpidase to Ohara. Ohara will be responsible for |